Genotypic analysis of plasmid-mediated β-lactamases amongst Enterobacteriaceae other than Escherichia spp. and Klebsiella spp. that are non-susceptible to a broad-spectrum cephalosporin

International Journal of Antimicrobial Agents

Volumn 36, Issue 4, 2010, Pages 343-347

  Kiratisin, Pattarachai ^a   Henprasert, Arunocha ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Lactamase; AmpC; Carbapenemase; Cephalosporins; Enterobacteriaceae; ESBL

Indexed keywords

BETA LACTAMASE AMPC; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEPHALOSPORIN; EXTENDED SPECTRUM BETA LACTAMASE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CITROBACTER FREUNDII; CITROBACTER KOSERI; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; GENETIC ANALYSIS; GENOTYPE; HUMAN; KLEBSIELLA; MALE; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROTEUS VULGARIS; PROVIDENCIA STUARTII; SALMONELLA; SERRATIA MARCESCENS;

BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; ENTEROBACTERIACEAE; ESCHERICHIA; HUMANS; KLEBSIELLA; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

EID: 77955923359     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.06.029     Document Type: Article

References (15)

1. Bush K., Jacoby G.A., Medeiros A.A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995, 39:1211-1233.
2. Bradford P.A. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001, 14:933-951.
3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI; 2010.
4. Paterson D.L., Bonomo R.A. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005, 18:657-686.
5. Jacoby G.A. AmpC β-lactamases. Clin Microbiol Rev 2009, 22:161-182.
6. Philippon A., Arlet G., Jacoby G.A. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 2002, 46:1-11.
7. Bradford P.A., Bratu S., Urban C., Visalli M., Mariano N., Landman D., et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City. Clin Infect Dis 2004, 39:55-60.
8. Marchaim D., Navon-Venezia S., Schwaber M.J., Carmeli Y. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother 2008, 52:1413-1418.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. Document M100-S16. Wayne, PA: CLSI; 2006.
10. Kiratisin P., Apisarnthanarak A., Laesripa C., Saifon P. Molecular characterization and epidemiology of extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother 2008, 52:2818-2824.
11. Perez-Perez F.J., Hanson N.D. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
12. Navon-Venezia S., Chmelnitsky I., Leavitt A., Schwaber M.J., Schwartz D., Carmeli Y. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 2009, 50:3098-3101.
13. Bennett J.W., Mende K., Herrera M.L., Yu X., Lewis J.S., Wickes B.L., et al. Mechanisms of carbapenem resistance among a collection of Enterobacteriaceae clinical isolates in a Texas city. Diagn Microbiol Infect Dis 2010, 66:445-448.
14. Alvarez M., Tran J.H., Chow N., Jacoby G.A. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob Agents Chemother 2004, 48:533-537.
15. Tenover F.C., Emery S.L., Spiegel C.A., Bradford P.A., Eells S., Endimiani A., et al. Identification of plasmid-mediated AmpC β-lactamases in Escherichia coli, Klebsiella spp., and Proteus species can potentially improve reporting of cephalosporin susceptibility testing results. J Clin Microbiol 2009, 47:294-299.